Many US patients opt for obesity drug injections, defying some expectations - Reuters
Many US patients opt for obesity drug injections, defying some expectations Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPTDhaVmptdGJGOTFReU82YkZ6RXRNdU9fSWNNQmhNRTctUUt0YXFkXzYzZ2JYTkZHZHhBekR6bEFId1RZZXJoYkNDdUlzRDhTSmNHa0FnZjR0SDZSaVRIRHpwUlMzZEtPcFgxdVZBVTFxNzZmWnNUcjByTnV0eklQLTEweDV3d2JyTm5FeExaUTBsOTg5VTNDNjhHWVY1Qm13dmxBeHpsQ0IzeGI3Y2JrcG1rYTBKeDlMSVA2MzNJSUI?oc=5" target="_blank">Many US patients opt for obesity drug injections, defying some expectations</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMEyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMIce cream makers bet consumers still want treats, just healthier ones - Reuters
Ice cream makers bet consumers still want treats, just healthier ones Reuters
August 13, 2026 at 06:27 AM